FOR IMMEDIATE RELEASEDecember 2025 A groundbreaking paper published this week in Redox Biology reveals the first clearly defined molecular target of molecular hydrogen (H₂), reshaping scientific understanding of how hydrogen exerts its therapeutic effects. The study, co-authored by Dr. Tyler W. LeBaron of the Molecular Hydrogen Institute (MHI), identifies the Rieske iron-sulfur protein (RISP), a…
The Molecular Hydrogen Institute (MHI) is hosting the first-ever Virtual Worldwide H2 Summit. This event has over 40 presenters from the best hydrogen researchers and medical doctors in the field. This virtual event is focused on exploring the therapeutic applications of molecular hydrogen including recent clinical insights, molecular mechanisms, and diverse applications in health, food,…
Throughout this month, we’ve taken our social media followers on an exciting journey through the world of molecular hydrogen research. We’ve shared short, engaging clips that spotlight some of the most interesting studies in this evolving field. These posts are more than just snippets—they’re highlighting the tireless efforts of scientists who are working to uncover…
We use cookies on this site to enhance your user experience. Learn more